Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: NCT07598396 ×

NCT07598396

This institution is selected. Its supporting articles are shown below.

NCT075983961

Articles mentioning NCT07598396

1 articles · page 1 of 1

Phase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosus

lupusscimed · abstract · 2026-06-17 · 1 matching annotations

80.1%

NCT07598396 Mosunetuzumab systemic lupus erythematosus SLE follicular lymphoma

…s currently being evaluated in a phase II study in severe SLE ( NCT07598396).Trial registration number NCT05155345.…